Cover Image
市場調查報告書

免疫化學分析儀:醫療設備的開發平台評估

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 351424
出版日期 內容資訊 英文 460 Pages
訂單完成後即時交付
價格
Back to Top
免疫化學分析儀:醫療設備的開發平台評估 Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年10月11日 內容資訊: 英文 460 Pages
簡介

本報告提供免疫化學分析儀的開發中產品相關調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的最近事件等資訊。

第1章 目錄

第2章 簡介

  • 免疫化學分析儀概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各市場區隔
  • 開發中產品:地區 (國家) 別
  • 開發中產品:法規途徑別
  • 開發中產品:核准時期別 (估計)
  • 進行中臨床實驗

第4章 免疫化學分析儀 - 正在開發的開發中產品:各企業

  • 免疫化學分析儀 Companies - 開發中產品:各開發階段
  • 開發中產品:各開發階段

第5章 免疫化學分析儀的開發企業與產品概要概要

  • Acreo Swedish ICT AB
  • AESKU.Diagnostics GmbH & Co. KG
  • Akonni Biosystems, Inc.
  • Arcxis Biotechnologies Inc.
  • Assay Dynamics, LLC
  • Atonomics A/S
  • Beckman Coulter, Inc.
  • BioMedomics, Inc
  • BioNanovations Corporation
  • BioSIMS
  • Boston University
  • Canon U.S.A., Inc.
  • CardioGenics Inc.
  • Celsee Diagnostics, Inc.
  • Cepheid
  • China Medical Technologies, Inc.
  • ChipCare Corp
  • Clearbridge BioLoc Pte Ltd
  • Corgenix Medical Corporation
  • Courtagen Life Sciences, Inc.
  • Curetis N.V.
  • Denator AB
  • DiaSorin S.p.A
  • Dyamed Biotech Pte Ltd
  • Dynex Technologies
  • EKF Diagnostics Holdings Plc
  • Enigma Diagnostics Limited
  • F Cubed LLC
  • Firalis SAS
  • First Light Biosciences, Inc.
  • Florida State University
  • GenePOC Inc.
  • Genera Biosystems Limited
  • Genevo Biosystems Pte Ltd
  • GenMark Diagnostics, Inc.
  • Global Solutions for Infectious Diseases
  • GNA Biosolutions GmbH
  • Harvard University
  • HeatFlow Technologies, Inc.
  • Hologic, Inc.
  • HTG Molecular Diagnostics, Inc.
  • Immunexpress Pty Ltd
  • Immunodiagnostic Systems Holdings plc
  • Intelligent Fingerprinting Ltd
  • Johnson & Johnson
  • LaserGen, Inc.
  • Lucerna, Inc.
  • Magellan Diagnostics, Inc.
  • Magnisense SAS
  • MAST GROUP Ltd.
  • Maxygen-mobile DNA tests
  • mBio Diagnostics, Inc.
  • McKesson Corporation
  • MedNostic Technologies, LLC
  • Mindray Medical International Limited
  • Mobidiag Ltd.
  • NanoLab, Inc.
  • Nanosphere, Inc.
  • Next Dimension Technologies, Inc.
  • NorthShore University Health System
  • OncoGenesis
  • Optidet Diagnostics Ltd
  • Optofluidics, Inc.
  • Ostendum R&D BV
  • Polymedco CDP, LLC
  • Protomex Life Sciences
  • Qiagen N.V.
  • Quanterix Corporation
  • QuantuMDx Group Limited
  • Quidel Corporation
  • Radisens Diagnostics Limited
  • Raman Diagnostics Limited
  • Rapid Biosensor Systems
  • Rapid Diagnostek, Inc.
  • Siemens Healthcare Diagnostics Inc.
  • Siloam Biosciences, Inc.
  • Singulex, Inc.
  • Spire Corporation
  • Stat-Diagnostica & Innovation, S.L.
  • STRATEC Molecular GmbH
  • Sysmex Corporation
  • Tecan Group Ltd
  • Techcomp (Holdings) Limited
  • The Palo Alto Research Center
  • TrovaGene, Inc.
  • Tyncbest Biotechnology
  • University of California, Davis
  • University of California, San Diego
  • University of Michigan
  • University of Michigan Pediatric Device Consortium
  • Wellstat Diagnostics, LLC
  • Xanthostat Diagnostics, Inc.
  • ZIN Technologies, Inc.

第6章 免疫化學分析儀 - 最近的事件

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0485EPD

GlobalData's Medical Devices sector report, "Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2017" provides an overview of Immunochemistry Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunochemistry Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Immunochemistry Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunochemistry Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunochemistry Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 11
  • 1.2 List of Figures 18

2 Introduction 19

  • 2.1 Immunochemistry Analyzers Overview 19

3 Products under Development 20

  • 3.1 Immunochemistry Analyzers - Pipeline Products by Stage of Development 20
  • 3.2 Immunochemistry Analyzers - Pipeline Products by Segment 21
  • 3.3 Immunochemistry Analyzers - Pipeline Products by Territory 22
  • 3.4 Immunochemistry Analyzers - Pipeline Products by Regulatory Path 23
  • 3.5 Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 24
  • 3.6 Immunochemistry Analyzers - Ongoing Clinical Trials 25

4 Immunochemistry Analyzers - Pipeline Products under Development by Companies 26

  • 4.1 Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development 26
  • 4.2 Immunochemistry Analyzers - Pipeline Products by Stage of Development 31

5 Immunochemistry Analyzers Companies and Product Overview 35

  • 5.1 Acreo Swedish ICT AB Company Overview 35
  • 5.2 AESKU.Diagnostics GmbH & Co KG Company Overview 36
  • 5.3 AgPlus Diagnostics LTD Company Overview 37
  • 5.4 Akers Biosciences Inc Company Overview 38
  • 5.5 Akonni Biosystems Inc Company Overview 39
  • 5.6 Alere Inc Company Overview 40
  • 5.7 Amic AB (Inactive) Company Overview 41
  • 5.8 Amplino B.V. Company Overview 42
  • 5.9 Analytical Diagnostic Solutions Inc Company Overview 43
  • 5.10 ApoCell Inc Company Overview 44
  • 5.11 Aquila Diagnostic Systems Inc. Company Overview 45
  • 5.12 Arcxis Biotechnologies Inc Company Overview 46
  • 5.13 Assay Dynamics LLC (Inactive) Company Overview 47
  • 5.14 Atonomics A/S Company Overview 48
  • 5.15 Attophotonics Biosciences GmbH Company Overview 51
  • 5.16 Beckman Coulter Inc Company Overview 52
  • 5.17 Binghamton University Company Overview 54
  • 5.18 Bio-Alternative Medical Devices Ltd Company Overview 55
  • 5.19 Biocartis SA Company Overview 56
  • 5.20 BioMedomics Inc Company Overview 57
  • 5.21 bioMerieux S.A. Company Overview 59
  • 5.22 BioNanovations Corporation Company Overview 60
  • 5.23 Biopico Systems Inc. Company Overview 61
  • 5.24 Biosan Medical Ltd. Company Overview 62
  • 5.25 BioSIMS Company Overview 63
  • 5.26 Boditech Med Inc Company Overview 64
  • 5.27 Boston University Company Overview 65
  • 5.28 BreviTest Technologies LLC Company Overview 68
  • 5.29 Canon U.S.A. Inc Company Overview 70
  • 5.30 CardioGenics Inc Company Overview 71
  • 5.31 Cepheid Company Overview 72
  • 5.32 China Medical Technologies Inc (Inactive) Company Overview 76
  • 5.33 ChipCare Corp Company Overview 78
  • 5.34 City, University of London Company Overview 81
  • 5.35 Clearbridge BioLoc Pte Ltd Company Overview 82
  • 5.36 Co-Diagnostics HBDC, Inc. Company Overview 83
  • 5.37 Corgenix Medical Corp Company Overview 84
  • 5.38 Courtagen Life Sciences Inc Company Overview 85
  • 5.39 Curetis NV Company Overview 86
  • 5.40 Denator AB Company Overview 87
  • 5.41 DiaSorin S.p.A Company Overview 88
  • 5.42 Dyamed Biotech Pte Ltd Company Overview 89
  • 5.43 Dynex Technologies Company Overview 90
  • 5.44 EKF Diagnostics Holdings Plc Company Overview 91
  • 5.45 EMD Millipore Corp Company Overview 92
  • 5.46 Enigma Diagnostics Ltd (Inactive) Company Overview 93
  • 5.47 Exosome Diagnostics Inc Company Overview 95
  • 5.48 Firalis SAS Company Overview 96
  • 5.49 First Light Biosciences, Inc. Company Overview 97
  • 5.50 Florida International University Company Overview 98
  • 5.51 Genera Biosystems Ltd Company Overview 99
  • 5.52 Genevo Biosystems Pte Ltd Company Overview 100
  • 5.53 GNA Biosolutions GmbH Company Overview 101
  • 5.54 Great Basin Scientific Inc Company Overview 102
  • 5.55 Harvard University Company Overview 103
  • 5.56 HeatFlow Technologies Inc Company Overview 104
  • 5.57 Hologic Inc Company Overview 105
  • 5.58 Indian Institute of Technology, Chennai Company Overview 107
  • 5.59 Indiana University Company Overview 108
  • 5.60 Inova Diagnostics Inc Company Overview 109
  • 5.61 LabNow Inc (Inactive) Company Overview 110
  • 5.62 LaserGen Inc Company Overview 111
  • 5.63 Lucerna Inc Company Overview 112
  • 5.64 Magellan Diagnostics Inc Company Overview 113
  • 5.65 Magna Diagnostics GmbH Company Overview 114
  • 5.66 MAST GROUP Ltd Company Overview 115
  • 5.67 Maxygen-mobile DNA tests Company Overview 116
  • 5.68 mBio Diagnostics Inc Company Overview 117
  • 5.69 McKesson Corp Company Overview 119
  • 5.70 MedNostic Technologies, LLC Company Overview 120
  • 5.71 Meridian Bioscience Inc Company Overview 121
  • 5.72 MML Ltd Company Overview 122
  • 5.73 Mobidiag Ltd Company Overview 123
  • 5.74 Molbio Diagnostics Pvt. Ltd. Company Overview 124
  • 5.75 Molecular Warehouse Ltd Company Overview 125
  • 5.76 Mologic Ltd Company Overview 126
  • 5.77 Nalia Systems Ltd Company Overview 127
  • 5.78 NanoLab Inc Company Overview 128
  • 5.79 Newcastle University Company Overview 130
  • 5.80 NorthShore University Health System Company Overview 131
  • 5.81 Ohmx Corp Company Overview 132
  • 5.82 OncoGenesis Company Overview 133
  • 5.83 OncoTherapy Science Inc Company Overview 134
  • 5.84 Ortho-Clinical Diagnostics Inc Company Overview 135
  • 5.85 Ostendum R&D BV Company Overview 136
  • 5.86 Pacific Nanoscience, Inc. Company Overview 137
  • 5.87 Parallax Health Sciences, Inc. Company Overview 138
  • 5.88 Phoenix Biosystems Inc Company Overview 139
  • 5.89 POC Medical Systems Inc. Company Overview 140
  • 5.90 Pocared Diagnostics Ltd. Company Overview 141
  • 5.91 Polymedco CDP, LLC Company Overview 142
  • 5.92 PositiveID Corp Company Overview 143
  • 5.93 Protomex Life Sciences Company Overview 145
  • 5.94 Qiagen NV Company Overview 146
  • 5.95 Quanterix Corp Company Overview 148
  • 5.96 Radisens Diagnostics Ltd Company Overview 149
  • 5.97 Raman Diagnostics Ltd Company Overview 150
  • 5.98 Rapid Diagnostek, Inc. Company Overview 151
  • 5.99 Roche Diagnostics International Ltd Company Overview 152
  • 5.100 Royal College of Surgeons in Ireland Company Overview 153
  • 5.101 Sebia SA Company Overview 154
  • 5.102 SenGenix Inc Company Overview 157
  • 5.103 Singulex Inc Company Overview 158
  • 5.104 Spectradyne LLC Company Overview 161
  • 5.105 SQI Diagnostics Inc Company Overview 162
  • 5.106 Stat-Diagnostica & Innovation SL Company Overview 163
  • 5.107 StemTek Therapeutics SL Company Overview 164
  • 5.108 STRATEC Molecular GmbH Company Overview 165
  • 5.109 Tecan Group Ltd Company Overview 166
  • 5.110 Techcomp (Holdings) Ltd Company Overview 167
  • 5.111 The Palo Alto Research Center Company Overview 169
  • 5.112 Thermal Gradient Inc Company Overview 170
  • 5.113 Trinity Biotech Plc Company Overview 172
  • 5.114 Two Pore Guys Inc Company Overview 173
  • 5.115 Tyncbest Biotechnology Company Overview 174
  • 5.116 University of California Berkeley Company Overview 175
  • 5.117 University of California San Diego Company Overview 178
  • 5.118 University of Michigan Pediatric Device Consortium Company Overview 179
  • 5.119 University of South Florida Company Overview 180
  • 5.120 ViroCyt Inc Company Overview 181
  • 5.121 Virogenomics BioDevelopment Inc Company Overview 182
  • 5.122 Wellstat Diagnostics LLC Company Overview 183
  • 5.123 Xanthostat Diagnostics Inc Company Overview 184

6 Immunochemistry Analyzers- Recent Developments 185

  • 6.1 Sep 20, 2017: Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis 185
  • 6.2 Sep 19, 2017: Internal Sample Preparation, Small Size and Rapid Results Differentiate the FireflyDX Systems, says Lyle Probst During BioWatch Panel 186
  • 6.3 Sep 19, 2017: Theradiag: Results and activity for the first half of 2017 Continued improvement in results 187
  • 6.4 Sep 18, 2017: Tetracore Announces European Approval of the T-COR 8 Portable Real-time PCR Thermocycler 188
  • 6.5 Sep 18, 2017: ARKRAY launches ADAMS A1c HA-8180V System for hemoglobin A1c testing 189
  • 6.6 Sep 18, 2017: biOasis Announces Rob Hutchison, Founder, to Retire as Chairman & Board Member 190
  • 6.7 Sep 18, 2017: HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements 191
  • 6.8 Sep 13, 2017: Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Second Consecutive Year 191
  • 6.9 Sep 12, 2017: PositiveID's ExcitePCR Subsidiary to Hold Press Conference Announcing Lawrence Livermore National Report on its FireflyDX 192
  • 6.10 Sep 11, 2017: EKF Diagnostics Holdings: Half Yearly Report 193
  • 6.11 Sep 11, 2017: AYOXXA introduces LUNARIS, its advanced fully integrated low-volume beads-on-a-chip multiplex protein analysis system 193
  • 6.12 Sep 05, 2017: Sysmex Begins Conducting Direct Sales and Services in Ghana 195
  • 6.13 Aug 31, 2017: VIRCELL Announces VirClia's Promotion 195
  • 6.14 Aug 30, 2017: PositiveID's ExcitePCR Subsidiary Announces FireflyDX-Portable: A Lightweight, Bookbag-sized, Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018 195
  • 6.15 Aug 30, 2017: bioMerieux - First-Half 2017 Results 197
  • 6.16 Aug 28, 2017: biOasis Announces Nominees to the Board of Directors, Chairman Transition and Details of its Annual General Meeting of Shareholders 200
  • 6.17 Aug 24, 2017: SQI Diagnostics Reports Third Quarter 2017 Results 202
  • 6.18 Aug 21, 2017: biOasis Appoints Doug Williams, MBA, Executive Vice President, Chief Business Officer 204
  • 6.19 Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson 204
  • 6.20 Aug 17, 2017: Biohit Group Half Year Financial Report 2017 205
  • 6.21 Aug 17, 2017: TATAA Biocenter Expands Its Real-Time PCR Offerings With Analytik Jena's qTOWER3 209
  • 6.22 Aug 17, 2017: Span Diagnostics announces resignation of CFO 210
  • 6.23 Aug 16, 2017: Two Pore Guys Announces Positive Results from Pilot Point-of-Care Liquid Biopsy Study with UCSF 210
  • 6.24 Aug 16, 2017: Curetis Announces Financial Results for the First Six Months of 2017 211
  • 6.25 Aug 16, 2017: Novacyt Half Year 2017 Results Consolidated sales growth +53% CER Group continues positive outlook for 2017 215
  • 6.26 Aug 16, 2017: Curetis Announces Management Board Changes 219
  • 6.27 Aug 16, 2017: H1 2017: Tecan with significant increase in order entry and strong sales growth in the Life Sciences Business 219
  • 6.28 Aug 16, 2017: Curetis Announces Financial Results for the First Six Months of 2017 222
  • 6.29 Aug 15, 2017: Quanterix To Launch High-Sensitivity Benchtop Instrument And Assays For Multiplex Biomarker Detection 225
  • 6.30 Aug 09, 2017: Trovagene Announces Second Quarter 2017 Company Highlights and Financial Results 227
  • 6.31 Aug 09, 2017: Cempra Provides Corporate Update and Reports Second Quarter 2017 Financial Results 228
  • 6.32 Aug 08, 2017: PositiveID Successfully Detects Ebola Virus on its Firefly Dx Prototype System 230
  • 6.33 Aug 08, 2017: HTG Molecular Diagnostics Reports Second Quarter 2017 Results 231
  • 6.34 Aug 03, 2017: Siemens extends appointment of CEO Joe Kaeser 231
  • 6.35 Aug 03, 2017: Siemens: Earnings Release Q3 FY 2017 232
  • 6.36 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter 234
  • 6.37 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 236
  • 6.38 Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results 236
  • 6.39 Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017 237
  • 6.40 Aug 02, 2017: Psychemedics Announces Q2 Earnings 241
  • 6.41 Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 242
  • 6.42 Aug 01, 2017: GenMark Reports Second Quarter 2017 Results 243
  • 6.43 Jul 31, 2017: Roche to showcase power of connected lab at AACC 2017 Clinical Lab Expo 244
  • 6.44 Jul 27, 2017: McKesson Reports Fiscal 2018 First-Quarter Results 245
  • 6.45 Jul 27, 2017: QIAGEN Reports Results for Second Quarter and First Half of 2017 246
  • 6.46 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 249
  • 6.47 Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results 251
  • 6.48 Jul 25, 2017: ERBA Diagnostics Appoints David Barka as Interim Chief Executive Officer, Nikhil Vazirani as Member of the Board 253
  • 6.49 Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9% 253
  • 6.50 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review 254
  • 6.51 Jul 20, 2017: Novacyt Revenues Half Year 2017 256
  • 6.52 Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results 257
  • 6.53 Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology 259
  • 6.54 Jul 18, 2017: Quanterix, Partners Develop PCR-free miRNA Detection Method for Liver Toxicity Testing 260
  • 6.55 Jul 13, 2017: Dr. Jaymie Sawyer, Vice President of R&D, Transitions to Lead Scientific Advisory Committee 261
  • 6.56 Jul 13, 2017: Parallax Health Sciences Appoints Paul Arena as Chief Executive Officer 261
  • 6.57 Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 264
  • 6.58 Jul 10, 2017: Trovagene Regains Compliance with NASDAQ Listing Requirements 264

7 Appendix 455

  • 7.1 Methodology 455
  • 7.2 About GlobalData 458
  • 7.3 Contact Us 458
  • 7.4 Disclaimer 458

List of Tables

1.1 List of Tables

  • Table 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development 22
  • Table 2: Immunochemistry Analyzers - Pipeline Products by Segment 23
  • Table 3: Immunochemistry Analyzers - Pipeline Products by Territory 24
  • Table 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path 25
  • Table 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 26
  • Table 6: Immunochemistry Analyzers - Ongoing Clinical Trials 27
  • Table 7: Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development 28
  • Table 8: Immunochemistry Analyzers - Pipeline Products by Stage of Development 33
  • Table 9: Acreo Swedish ICT AB Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 10: Electronic Nanowire Bio - Sensor - Product Status 37
  • Table 11: Electronic Nanowire Bio - Sensor - Product Description 37
  • Table 12: AESKU.Diagnostics GmbH & Co KG Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 13: HELIA Immunoassay Analyzer - Product Status 38
  • Table 14: HELIA Immunoassay Analyzer - Product Description 38
  • Table 15: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 16: AgPlus Diagnostic System - Product Status 39
  • Table 17: AgPlus Diagnostic System - Product Description 39
  • Table 18: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 19: minDNAnalyzer - Product Status 40
  • Table 20: minDNAnalyzer - Product Description 40
  • Table 21: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 22: TruDx 2000 Platform - Product Status 41
  • Table 23: TruDx 2000 Platform - Product Description 41
  • Table 24: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 25: Clondiag HIV Molecular Device - Product Status 42
  • Table 26: Clondiag HIV Molecular Device - Product Description 42
  • Table 27: Amic AB (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 28: Optical Fluorescence Reader - Product Status 43
  • Table 29: Optical Fluorescence Reader - Product Description 43
  • Table 30: Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 31: Scout PCR Analyzer - Product Status 44
  • Table 32: Scout PCR Analyzer - Product Description 44
  • Table 33: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 34: POC Device - Malaria - Product Status 45
  • Table 35: POC Device - Malaria - Product Description 45
  • Table 36: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 37: ApoStream System - Product Status 46
  • Table 38: ApoStream System - Product Description 46
  • Table 39: Aquila Diagnostic Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 40: Accutas Malaria Diagnostic System - Product Status 47
  • Table 41: Accutas Malaria Diagnostic System - Product Description 47
  • Table 42: Arcxis Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 43: BioPhalanx Analyzer - Product Status 48
  • Table 44: BioPhalanx Analyzer - Product Description 48
  • Table 45: Assay Dynamics LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 46: Automated Diagnostic Device - Product Status 49
  • Table 47: Automated Diagnostic Device - Product Description 49
  • Table 48: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 49: Atolyzer Consumer Device - Product Status 50
  • Table 50: Atolyzer Consumer Device - Product Description 50
  • Table 51: Atolyzer Gene - Product Status 51
  • Table 52: Atolyzer Gene - Product Description 51
  • Table 53: Atolyzer PoC - Product Status 51
  • Table 54: Atolyzer PoC - Product Description 52
  • Table 55: Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 56: Nanoparticle Microfluidic Color Device - Product Status 53
  • Table 57: Nanoparticle Microfluidic Color Device - Product Description 53
  • Table 58: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 59: DxN VERIS MDx System - Product Status 54
  • Table 60: DxN VERIS MDx System - Product Description 54
  • Table 61: UniCel DxN - Product Status 55
  • Table 62: UniCel DxN - Product Description 55
  • Table 63: Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 64: U-PAC - Product Status 56
  • Table 65: U-PAC - Product Description 56
  • Table 66: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 67: Magnetic Immunoassay Detection System - Product Status 57
  • Table 68: Magnetic Immunoassay Detection System - Product Description 57
  • Table 69: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 70: Idylla System - Product Status 58
  • Table 71: Idylla System - Product Description 58
  • Table 72: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 73: Next Generation Ultra-sensitive Nanotube Platform - Product Status 59
  • Table 74: Next Generation Ultra-sensitive Nanotube Platform - Product Description 59
  • Table 75: TR-LFIA Diagnostic Platform - Product Status 60
  • Table 76: TR-LFIA Diagnostic Platform - Product Description 60
  • Table 77: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 78: Magnotech System - Product Status 61
  • Table 79: Magnotech System - Product Description 61
  • Table 80: BioNanovations Corporation Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 81: TestQuick - Product Status 62
  • Table 82: TestQuick - Product Description 62
  • Table 83: Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 84: MONITOR System - Product Status 63
  • Table 85: MONITOR System - Product Description 63
  • Table 86: Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 87: DNA And Protein Array Scanner System - Product Status 64
  • Table 88: DNA And Protein Array Scanner System - Product Description 64
  • Table 89: BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 90: DigiPLEX Analyzer - Product Status 65
  • Table 91: DigiPLEX Analyzer - Product Description 65
  • Table 92: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 93: AFIAS6 - Product Status 66
  • Table 94: AFIAS6 - Product Description 66
  • Table 95: Boston University Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 96: Lab-On-A-Chip - Thyroid Cancer - Product Status 67
  • Table 97: Lab-On-A-Chip - Thyroid Cancer - Product Description 67
  • Table 98: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Status 68
  • Table 99: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Description 68
  • Table 100: Point-Of-Care Device - Allergen-Specific IgE - Product Status 68
  • Table 101: Point-Of-Care Device - Allergen-Specific IgE - Product Description 69
  • Table 102: BreviTest Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 103: BreviTest Portable Analyzer - Product Status 70
  • Table 104: BreviTest Portable Analyzer - Product Description 70
  • Table 105: BreviTest Robotic Analyzer - Product Status 71
  • Table 106: BreviTest Robotic Analyzer - Product Description 71
  • Table 107: Canon U.S.A. Inc Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 108: Automated Diagnostic System - Infectious Disease - Product Status 72
  • Table 109: Automated Diagnostic System - Infectious Disease - Product Description 72
  • Table 110: CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 111: QL Care Analyzer - Product Status 73
  • Table 112: QL Care Analyzer - Product Description 73
  • Table 113: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 114: GeneXpert Omni - Product Status 74
  • Table 115: GeneXpert Omni - Product Description 74
  • Table 116: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Status 75
  • Table 117: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Description 75
  • Table 118: Cepheid - Ongoing Clinical Trials Overview 76
  • Table 119: GeneXpert Omni - Xpert Omni Performance Evaluation for Linkage to Tuberculosis Care: The XPEL TB Trial 77
  • Table 120: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 121: AUTOLIA-12/48 - Product Status 78
  • Table 122: AUTOLIA-12/48 - Product Description 78
  • Table 123: SPR Analyzer - Product Status 79
  • Table 124: SPR Analyzer - Product Description 79
  • Table 125: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 126: Polyvalent Analyzer (PAx) - Product Status 80
  • Table 127: Polyvalent Analyzer (PAx) - Product Description 80
  • Table 128: Portable Cell Analyzer - Food Borne Diseases - Product Status 81
  • Table 129: Portable Cell Analyzer - Food Borne Diseases - Product Description 81
  • Table 130: Portable Cell Analyzer - Malaria - Product Status 81
  • Table 131: Portable Cell Analyzer - Malaria - Product Description 82
  • Table 132: Portable Cell Analyzer - Tuberculosis - Product Status 82
  • Table 133: Portable Cell Analyzer - Tuberculosis - Product Description 82
  • Table 134: City, University of London Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 135: POC Device - Mood Disorders - Product Status 83
  • Table 136: POC Device - Mood Disorders - Product Description 83
  • Table 137: Clearbridge BioLoc Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 138: AssayQuest - Product Status 84
  • Table 139: AssayQuest - Product Description 84
  • Table 140: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 141: LightPCR - Product Status 85
  • Table 142: LightPCR - Product Description 85
  • Table 143: Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 144: ELISA Microplate Reader - Product Status 86
  • Table 145: ELISA Microplate Reader - Product Description 86
  • Table 146: Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 147: Avantra Q400 Biomarker Workstation - Product Status 87
  • Table 148: Avantra Q400 Biomarker Workstation - Product Description 87
  • Table 149: Curetis NV Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 150: Gyronimo Analyzer - Product Status 88
  • Table 151: Gyronimo Analyzer - Product Description 88
  • Table 152: Denator AB Pipeline Products & Ongoing Clinical Trials Overview 89
  • Table 153: Biomarker Discovery Platform - Cancer - Product Status 89
  • Table 154: Biomarker Discovery Platform - Cancer - Product Description 89
  • Table 155: DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 90
  • Table 156: LIAISON XS - Product Status 90
  • Table 157: LIAISON XS - Product Description 90
  • Table 158: Dyamed Biotech Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 159: MicroKit AIO - Product Status 91
  • Table 160: MicroKit AIO - Product Description 91
  • Table 161: Dynex Technologies Pipeline Products & Ongoing Clinical Trials Overview 92
  • Table 162: Agility 12-Plate System - Product Status 92
  • Table 163: Agility 12-Plate System - Product Description 92
  • Table 164: EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 93
  • Table 165: BIOSEN HbA1c Instrument - Product Status 93
  • Table 166: BIOSEN HbA1c Instrument - Product Description 93
  • Table 167: EMD Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 94

List of Figures

1.2 List of Figures

  • Figure 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development 22
  • Figure 2: Immunochemistry Analyzers - Pipeline Products by Segment 23
  • Figure 3: Immunochemistry Analyzers - Pipeline Products by Territory 24
  • Figure 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path 25
  • Figure 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 26
  • Figure 6: Immunochemistry Analyzers - Ongoing Clinical Trials 27
Back to Top